References
- Harker, L.A. and Finch, C.A. (1969) "Thrombokinetics in man", J. Clin. Investig. 48, 963–974.
- Kaushansky, K. (1995) "Thrombopoietin: the primary regulator of platelet production", Blood 86, 419–431.
- Debili, N., Masse, J.M., Katz, A., et al. (1993) "Effects of recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells", Blood 82, 84–95.
- Avraham, H., Vannier, E., Cowley, S., et al. (1992) "Effects of stem cell factor, c-kit ligand, on human megakaryocytic cells", Blood 79, 365–371.
- Briddell, R.A., Bruno, E., Cooper, R.J., et al. (1991) "Effect of c-kit ligand on in vitro human megakaryocytopoiesis", Blood 78, 2854–2859.
- Kavnoudias, H., Jackson, H., Ettlinger, K., et al. (1992) "Interleukin-3 directly stimulates both megakaryocyte pro-genitor cells and immature megakaryocytes", Exp. Hematol. 20, 43–46.
- Ishibashi, T., Kimura, H., Shikama, Y., et al. (1989) "Interleukin-6 is a potent thrombopoietic factor in vivo in mice", Blood 74, 1241–1244.
- Bruno, E., Briddell, R.A., Cooper, R.J., et al. (1991) "Effects of recombinant human interleukin-11 on human megakaryocyte progenitor cells", Exp. Hematol. 19, 378–381.
- Broudy, V.C., Lin, N.L. and Kaushansky, K. (1995) "Thrombo-poietin (c-mpl ligand) acts synergistically with erythropoie-tin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro", Blood 85, 1719–1726.
- Long, M.W., Hutchinson, R.J., Gragowski, L.L., et al. (1988) "Synergistic regulation of human megakaryocyte develop-ment", J. Clin. Investig. 82, 1779–1786.
- Anderson, D.M., Lyman, S.D., Baird, A., et al. (1990) "Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms", Cell 63, 235–243.
- Papayannopoulou, T., Brice, M., Broudy, V.C., et al. (1991) "Isolation of c-kit expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile", Blood 78, 1403–1412.
- Veiby, O.P., Mikhail, A.A. and Snodgrass, H.R. (1997) "Growth factors and hematopoietic stem cells", Hematol. Oncol. Clin. North Am. 11, 1173–1184.
- Flanagan, J.G., Chan, O.C. and Leder, P. (1991) "Trans-membrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Slc mutant", Cell 64, 1025–1035.
- Ashman, L.K. (1999) "The biology of the stem cell factor and its receptor c-kit", Int. J. Biochem. Cell Biol. 31, 1037–1051.
- Kimura, E, Nakamura, Y, Sato, K., et al. (1996) "Cyclic changes of cytokines in a patient with cyclic thrombocyto-penia", Br. J. Haematol. 94, 171–174.
- Hsu, H.C., Tsai, W.H., Jiang, M.L., et al. (1999) "Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis", J. Lab. Clin. Med. 134, 392–397.
- Nakagawa, S. and Kitoh, T. (2000) "Measurement of KIT ligand /stem cell factor: clinical and biochemical signifi-cance", Curr. Opin. Hematol. 7, 133–142.
- Murphy, S., Rand, H., Rosenthal, D., et al. (1986) "Essential thrombocytemia: an interim report from the polycytehemia Vera Study Group", Semin. Hematol. 23, 177–182.
- Klinken, P. (1999) "Regulation of the hemopoietic system", Int. J. Biochem. Cell Biol. 31, 983–989.
- Lorgeot, V, Trimoreau, N., Gachard, V, et al. (1997) "Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies", Fur. Cytokine Netw. 8, 57–59.
- Hunt, P., Zsebo, K.M., Hokom, M.M., et al. (1992) "Evidence that stem cell factor is involved in the rebound thrombo-cytosis that follows 5-FU treatment", Blood 80, 904–911.